PATENT CLAIM ANALYSIS

Application Number: 16296012
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["514", "356000"]

Abstract:
Disclosed herein are methods of treating disease with a combination of a RXR agonist and a thyroid hormone.

Claim (Index 1):
A method of promoting survival or repair of neurons or glial cells in a patient with Alzheimer's disease, the method comprising administering to an individual in need thereof a therapeutically effective amount of a RXR agonist and a thyroid hormone, wherein the RXR agonist is 3,7-dimethyl-6(S),7(S)-methano,7-[1,1,4,4-tetramethyl-1,2,3,4-tetrahydronaphth-7-yl]2(E),4(E) heptadienoic acid, and has the structure of formula III: and administration of the combination of the RXR agonist and the thyroid hormone promotes survival or repair of neurons or glial cells in the individual more effectively than administration of the selective RXR agonist or thyroid hormone alone.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 99.0
- Lexical Diversity: 1.1875
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16118001', '15339762', '15812821', '15339752', '14507730']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8374376575479207
- 35 USC 102 Novelty (BERT): 0.7096593644644255
- Combined Prediction Score: 0.8246598282395712
- Mean Citation Score: 701.6502839999997
- Max Citation Score: 781.9381
- Similarity Product: 735.334965527427

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test